Suchergebnisse - "Heil, Emily L"

PubPharm (144)

11

Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatients

enthalten in: JAC-antimicrobial resistance | 2023

von Baghdadi, J. | Goodman, K. | Magder, L. | +4

12

Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von McAteer, J. | Lee, J. | Cosgrove, S. | +9

CommentIn: Clin Infect Dis. 2023 May 3;76(9):1613-1614. - PMID 36631160

13

Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Heil, E. | Claeys, K. | Kline, E. | +8

14

Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients

enthalten in: Hepatology communications | 2023

von Liu, K. | Stern, S. | Heil, E. | +4

15

Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Goodman, K. | Baghdadi, J. | Magder, L. | +6

16

The UTH-UMB Global Health Education Collaboration : Building a Bidirectional Exchange Based on Equity and Reciprocity

enthalten in: Annals of global health | 2023

von Mupeta, F. | Sivile, S. | Toeque, M. | +19

17

Antimicrobials in Animal Agriculture in the United States : A Multidisciplinary Overview of Regulation and Utilization to Foster Collaboration: On Behalf Of the Society of Infectious Diseases Pharmacists

enthalten in: Open forum infectious diseases | 2022

von Gens, K. | Singer, R. | Dilworth, T. | +2

18

No Crystal Ball? Using Risk Factors and Scoring Systems to Predict Extended-Spectrum Beta-Lactamase Producing Enterobacterales (ESBL-E) and Carbapenem-Resistant Enterobacterales (CRE) Infections

enthalten in: Current infectious disease reports | 2022

von Li, C. | Claeys, K. | Justo, J. | +1

19

No Crystal Ball? Using Risk Factors and Scoring Systems to Predict Extended-Spectrum Beta-Lactamase Producing Enterobacterales (ESBL-E) and Carbapenem-Resistant Enterobacterales (CRE) Infections

enthalten in: Current infectious disease reports | 2022

von Li, C. | Claeys, K. | Justo, J. | +1

20

No Crystal Ball? Using Risk Factors and Scoring Systems to Predict Extended-Spectrum Beta-Lactamase Producing Enterobacterales (ESBL-E) and Carbapenem-Resistant Enterobacterales (CRE) Infections

enthalten in: Current infectious disease reports | 2022

von Li, C. | Claeys, K. | Justo, J. | +1